Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012103310> ?p ?o ?g. }
- W2012103310 endingPage "38389" @default.
- W2012103310 startingPage "38383" @default.
- W2012103310 abstract "Several clotrimazole (CLT) and 4-aminoquinoline derivatives were synthesized and found to exhibit in vitro antiplasmodial activity with IC50 ranging from nm to μm values. We report here that some of these compounds produce inhibition of rabbit sarcoplasmic reticulum Ca2+-ATPase (SERCA1) with IC50 values in the μm range. The highest affinity for the Ca2+-ATPase was observed with NF1442 (N-((3-chlorophenyl)(4-((4-(7-chloroquinolin-4-yl)piperazin-1-yl)methyl)phenyl)methyl)-7-chloro-4-aminoquinoline) and NF1058 (N-((3-chlorophenyl)(4-(pyrrolidin-1-ylmethyl)phenyl)methyl)-7-chloro-4-aminoquinoline),yielding IC50 values of 1.3 and 8.0 μm as demonstrated by measurements of steady state ATPase activity as well as single cycle charge transfer. Characterization of sequential reactions comprising the ATPase catalytic and transport cycle then demonstrated that NF1058, and similarly CLT, interferes with the mechanism of Ca2+ binding and Ca2+-dependent enzyme activation (E2 to E1·Ca2 transition) required for formation of phosphorylated intermediate by ATP utilization. On the other hand, Ca2+ independent phosphoenzyme formation by utilization of Pi (i.e. reverse of the hydrolytic reaction in the absence of Ca2+) was not inhibited by NF1058 or CLT. Comparative experiments showed that the high affinity inhibitor thapsigargin interferes not only with Ca2+ binding and phosphoenzyme formation with ATP but also with phosphoenzyme formation by utilization of Pi even though this reaction does not require Ca2+. It is concluded that NF1058 and CLT inhibit SERCA by stabilization of an E2 state that, as opposed to that obtained with thapsigargin, retains the functional ability to form E2-P by reacting with Pi. Several clotrimazole (CLT) and 4-aminoquinoline derivatives were synthesized and found to exhibit in vitro antiplasmodial activity with IC50 ranging from nm to μm values. We report here that some of these compounds produce inhibition of rabbit sarcoplasmic reticulum Ca2+-ATPase (SERCA1) with IC50 values in the μm range. The highest affinity for the Ca2+-ATPase was observed with NF1442 (N-((3-chlorophenyl)(4-((4-(7-chloroquinolin-4-yl)piperazin-1-yl)methyl)phenyl)methyl)-7-chloro-4-aminoquinoline) and NF1058 (N-((3-chlorophenyl)(4-(pyrrolidin-1-ylmethyl)phenyl)methyl)-7-chloro-4-aminoquinoline),yielding IC50 values of 1.3 and 8.0 μm as demonstrated by measurements of steady state ATPase activity as well as single cycle charge transfer. Characterization of sequential reactions comprising the ATPase catalytic and transport cycle then demonstrated that NF1058, and similarly CLT, interferes with the mechanism of Ca2+ binding and Ca2+-dependent enzyme activation (E2 to E1·Ca2 transition) required for formation of phosphorylated intermediate by ATP utilization. On the other hand, Ca2+ independent phosphoenzyme formation by utilization of Pi (i.e. reverse of the hydrolytic reaction in the absence of Ca2+) was not inhibited by NF1058 or CLT. Comparative experiments showed that the high affinity inhibitor thapsigargin interferes not only with Ca2+ binding and phosphoenzyme formation with ATP but also with phosphoenzyme formation by utilization of Pi even though this reaction does not require Ca2+. It is concluded that NF1058 and CLT inhibit SERCA by stabilization of an E2 state that, as opposed to that obtained with thapsigargin, retains the functional ability to form E2-P by reacting with Pi." @default.
- W2012103310 created "2016-06-24" @default.
- W2012103310 creator A5004950855 @default.
- W2012103310 creator A5011581658 @default.
- W2012103310 creator A5015069863 @default.
- W2012103310 creator A5045352304 @default.
- W2012103310 creator A5069926463 @default.
- W2012103310 creator A5071462506 @default.
- W2012103310 creator A5074112445 @default.
- W2012103310 creator A5084867757 @default.
- W2012103310 creator A5087526774 @default.
- W2012103310 date "2011-11-01" @default.
- W2012103310 modified "2023-09-28" @default.
- W2012103310 title "The Ca2+-ATPase (SERCA1) Is Inhibited by 4-Aminoquinoline Derivatives through Interference with Catalytic Activation by Ca2+, Whereas the ATPase E2 State Remains Functional" @default.
- W2012103310 cites W1164720054 @default.
- W2012103310 cites W1530822737 @default.
- W2012103310 cites W1571332834 @default.
- W2012103310 cites W1577394370 @default.
- W2012103310 cites W1588188747 @default.
- W2012103310 cites W1593385535 @default.
- W2012103310 cites W1775749144 @default.
- W2012103310 cites W1932843942 @default.
- W2012103310 cites W1964345983 @default.
- W2012103310 cites W1965681212 @default.
- W2012103310 cites W1984948704 @default.
- W2012103310 cites W1990106523 @default.
- W2012103310 cites W1990568326 @default.
- W2012103310 cites W1991596000 @default.
- W2012103310 cites W1996325724 @default.
- W2012103310 cites W2002493404 @default.
- W2012103310 cites W2014429457 @default.
- W2012103310 cites W2014681074 @default.
- W2012103310 cites W2015710917 @default.
- W2012103310 cites W2022703044 @default.
- W2012103310 cites W2026469080 @default.
- W2012103310 cites W2029029518 @default.
- W2012103310 cites W2030578434 @default.
- W2012103310 cites W2030966306 @default.
- W2012103310 cites W2037971636 @default.
- W2012103310 cites W2041716001 @default.
- W2012103310 cites W2043970808 @default.
- W2012103310 cites W2052061039 @default.
- W2012103310 cites W2053229854 @default.
- W2012103310 cites W2053841505 @default.
- W2012103310 cites W2058985732 @default.
- W2012103310 cites W2064495001 @default.
- W2012103310 cites W2065940471 @default.
- W2012103310 cites W2073418676 @default.
- W2012103310 cites W2077421755 @default.
- W2012103310 cites W2085514543 @default.
- W2012103310 cites W2091565573 @default.
- W2012103310 cites W2098550162 @default.
- W2012103310 cites W2124034869 @default.
- W2012103310 cites W2124720239 @default.
- W2012103310 cites W2134177599 @default.
- W2012103310 cites W2135393487 @default.
- W2012103310 cites W2153331570 @default.
- W2012103310 cites W2169297695 @default.
- W2012103310 doi "https://doi.org/10.1074/jbc.m111.287276" @default.
- W2012103310 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3207476" @default.
- W2012103310 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21914795" @default.
- W2012103310 hasPublicationYear "2011" @default.
- W2012103310 type Work @default.
- W2012103310 sameAs 2012103310 @default.
- W2012103310 citedByCount "12" @default.
- W2012103310 countsByYear W20121033102013 @default.
- W2012103310 countsByYear W20121033102014 @default.
- W2012103310 countsByYear W20121033102015 @default.
- W2012103310 countsByYear W20121033102016 @default.
- W2012103310 countsByYear W20121033102017 @default.
- W2012103310 countsByYear W20121033102018 @default.
- W2012103310 countsByYear W20121033102020 @default.
- W2012103310 countsByYear W20121033102021 @default.
- W2012103310 crossrefType "journal-article" @default.
- W2012103310 hasAuthorship W2012103310A5004950855 @default.
- W2012103310 hasAuthorship W2012103310A5011581658 @default.
- W2012103310 hasAuthorship W2012103310A5015069863 @default.
- W2012103310 hasAuthorship W2012103310A5045352304 @default.
- W2012103310 hasAuthorship W2012103310A5069926463 @default.
- W2012103310 hasAuthorship W2012103310A5071462506 @default.
- W2012103310 hasAuthorship W2012103310A5074112445 @default.
- W2012103310 hasAuthorship W2012103310A5084867757 @default.
- W2012103310 hasAuthorship W2012103310A5087526774 @default.
- W2012103310 hasBestOaLocation W20121033101 @default.
- W2012103310 hasConcept C101571972 @default.
- W2012103310 hasConcept C12554922 @default.
- W2012103310 hasConcept C141315368 @default.
- W2012103310 hasConcept C158617107 @default.
- W2012103310 hasConcept C181199279 @default.
- W2012103310 hasConcept C185592680 @default.
- W2012103310 hasConcept C202751555 @default.
- W2012103310 hasConcept C23265538 @default.
- W2012103310 hasConcept C2777146706 @default.
- W2012103310 hasConcept C2777752497 @default.
- W2012103310 hasConcept C2781414619 @default.
- W2012103310 hasConcept C55493867 @default.
- W2012103310 hasConcept C71240020 @default.
- W2012103310 hasConcept C86803240 @default.